News

The remainder of 2025 will be busy for Vir Biotechnology as it strives to successfully pivot to developing cancer and infectious disease therapies.
OpenCRISPR-1, an AI-generated custom gene editor capable of precision editing of the human genome. is just the beginning of ...
The data shows that RORDEP-proteins boost the production of hormones like GLP-1 and PYY, which help regulate appetite and ...
The Waltham Innovation Center will complement Aldevron’s established scientific teams in Fargo, ND, and Madison, WI.
Findings reinforce the need for approaches to minimize the risk of awakening lung DCCs and metastatic disease in cancer survivors who develop respiratory virus infections.
DEK will provide essential infrastructure and expertise to support Bio Usawa's market entry and expansion across West Africa.
When infiltrating the body, mechanical stress on cancer cells leads to rapid localization of mitochondria to the surface of the nucleus.
They’ve developed an AI-driven “Virtual Lab,” through which a team of AI agents, each equipped with varied scientific ...
In this GEN webinar, David Ezra Gordon, PhD, will describe a proteomics-driven approach for studying T-cell exhaustion to ...
The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute ...
AAV gene therapy in early life provides lasting HIV protection in primates—offering hope for pediatric HIV intervention in ...
Quartic.ai has seen an increase in front-line customers scaling their software to work across multiple manufacturing ...